KF
EBS icon

Krilogy Financial’s Emergent Biosolutions EBS Stock Holding History

Krilogy Financial’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed -$8K – 782
2017
Q3 		$8K Hold
200
– – ﹤0.01% 599
2017
Q2 		$7K Buy
200
+50
+33% +$1.54K ﹤0.01% 563
2017
Q1 		$5K Hold
150
– – ﹤0.01% 574
2016
Q4 		$5K Hold
150
– – ﹤0.01% 574
2016
Q3 		$5K Buy
150
+50
+50% +$1.45K ﹤0.01% 592
2016
Q2 		$3K Buy
+100
New +$3.92K ﹤0.01% 648

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return